Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective January 14, 2022, Grant F. Sanders resigned as Chairman and Chief Executive Officer of the Registrant and as Chairman of its wholly owned Canadian subsidiary ("Instadose Canada"). Mr. Sanders will not hold any officer or director positions at the Registrant or Instadose Canada following his resignation.

On January 14, 2022, Alex Wylie was appointed interim Chairman and interim Chief Executive Officer of the Registrant and Instadose Canada. Mr. Wylie will continue in his role as Chief Financial Officer of the Registrant and Instadose Canada. The Registrant's Board of Directors will initiate a process to find a permanent Chairman and Chief Executive Officer of the Registrant and Instadose Canada. Alex Wylie will be a potential candidate for the roles of Chairman and/or Chief Executive Officer in the Registrant and Instadose Canada.

The biography and a brief description of any material plan, contract or arrangement for Mr. Wylie is set forth in the Form 8-K, Item 2.01(f) filed on January 7, 2021.

Immediately upon appointment of the above individuals, the Registrant accepted the resignation of Grant Sanders from the Board of Directors and all management positions he had held with the Registrant.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.




Exhibit
No.       Description
  99        Press Release dated January 14, 2022





2

© Edgar Online, source Glimpses